GATE Biomaterials and Tissue Engineering: Biocompatibility and Implant Characteristics – Previous Year Questions
11 GATE previous year questions on Biocompatibility and Implant Characteristics (Biomaterials and Tissue Engineering, Biomedical Engineering) with answers and explanations, from every paper.
- GATE 2020 BM Q14 – Shape-memory biomaterials are NOT used in which listed application?
- GATE 2020 BM Q48 – A degradable surgical suture loses 40% of its original tensile strength after 10 days and 50% after 20 days. Assuming exponential decay, what closest…
- GATE 2021 BM Q30 – Which mechanisms may cause bone-implant failure?
- GATE 2022 BM Q27 – Which properties should an ideal coronary stent have?
- GATE 2023 BM Q52 – By which mechanisms can a water-insoluble polymeric biomaterial become water-soluble in vivo?
- GATE 2023 BM Q59 – In a 24-hour cell-viability assay with 10000 cells and absorbance measured at 570 nm, control absorbance is 0.8, treated absorbance 0.5 and blank…
- GATE 2024 BM Q20 – Which cumulative drug-release curve is ideal for an implantable slow-release delivery device?
- GATE 2024 BM Q41 – Over six months, the orthopaedic implant’s normalized molecular weight falls first, mechanical strength falls next, and mass remains initially near…
- GATE 2025 BM Q61 – Suture strength obeys σ=σ0−2 ln(t) for t≥1 week. If strength is 2 MPa at week 4, find strength at week 8 in MPa to two decimal places.
- GATE 2026 BM Q36 – A drug is loaded into a polymeric device. Which ratio defines encapsulation efficiency?
- GATE 2026 BM Q37 – Which complement pathway is most likely activated on implanted biomaterials in a healthy human?